Advanced breast cancer: Are the traditional stratification parameters still of value when patients are treated with combination chemotherapy?
- 1 April 1979
- journal article
- research article
- Published by Elsevier
- Vol. 15 (4) , 565-571
- https://doi.org/10.1016/0014-2964(79)90094-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prognostic Factors in the Initial Response to Therapy by Patients With Advanced Breast Cancer 2JNCI Journal of the National Cancer Institute, 1978
- Sequential combination chemotherapy in advanced breast cancerCancer Chemotherapy and Pharmacology, 1978
- Present Status of Combination Chemotherapy in Advanced Breast CancerPublished by S. Karger AG ,1977
- Combined chemo- and hormonal therapy in advanced breast cancerCancer, 1977
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976
- Response and survival in advanced breast cancer after two non-cross-resistant combinations.BMJ, 1976
- An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristineCancer, 1975
- Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancerCancer, 1975
- Treatment of Metastatic Breast Cancer with Cyclophosphamide, Methotrexate, Vincristine and Fluorouracil.Tumori Journal, 1973